Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Sonja Kappel-Latif"'
Autor:
Sonja Kappel-Latif, Prasanti Kotagiri, Lukas Schlager, Gabor Schuld, Natalie Walterskirchen, Vanessa Schimek, Gavin Sewell, Carina Binder, Johanna Jobst, Supriya Murthy, Barbara Messner, Stefanie Dabsch, Arthur Kaser, Paul A. Lyons, Michael Bergmann, Anton Stift, Rudolf Oehler, Lukas W. Unger
Publikováno v:
Cellular and Molecular Gastroenterology and Hepatology, Vol 17, Iss 4, Pp 662-666 (2024)
Externí odkaz:
https://doaj.org/article/76bfdf33c2854d3bb95d4b5ee3cd5107
Autor:
Sonja, Kappel-Latif, Johannes, Zacherl, Michael, Hejna, Maria, Westerhoff, Dietmar, Tamandl, Ahmed, Ba-Ssalamah, Martina, Mittlböck, Brigitte, Wolf, Friedrich, Wrba, Irene, Kührer, Ursula, Pluschnig, Sebastian F, Schoppmann, Reinhold, Függer, Ronald, Zwrtek, Karl, Glaser, Josef, Karner, Friedrich, Längle, Etienne, Wenzl, Rudolf, Roka, Dietmar, Öfner, Jörg, Tschmelitsch, Michael, Hold, Felix, Keil, Michael, Gnant, Daniela, Kandioler, O, Dietze
Publikováno v:
European Surgery
Summary Background In operable esophageal cancer patients, neoadjuvant therapy benefits only those who respond to the treatment. The • Pancho trial represents the first prospective randomized trial evaluating the relevance of the mark53 status for
Autor:
Lindsay Brammen, Martina Mittlböck, Kausilia K. Krishnadath, Irene Kührer, Tamara Braunschmid, Wayne A. Phillips, Maria Westerhoff, Daniela Kandioler, Michael Gnant, Sonja Kappel-Latif
Publikováno v:
Annals of the New York Academy of Sciences, 1434(1), 46-53. Wiley-Blackwell
Technological progress within the last 15–20 years has significantly increased our knowledge about the molecular basis of cancer development, tumor progression, and treatment response. As a consequence, a vast number of biomarkers have been propose